Cookie Consent vs HIPAA Authorization: They're Not the Same Thing

Two Permission Slips That Solve Different Problems

A hospital's marketing director installs a cookie consent banner on the organization's website. Visitors see a clean popup: "We use cookies to improve your experience and measure site performance. By clicking Accept, you consent to our use of cookies." The implementation follows GDPR best practices. The banner blocks analytics scripts until the visitor clicks Accept. The consent management platform logs every choice with a timestamp and IP address.

The marketing director checks the compliance box and moves on.

Six months later, the compliance officer reviews the site and asks a different question: does clicking "Accept" on this cookie banner constitute HIPAA authorization for sharing protected health information with Google, Meta, and your other analytics vendors?

The answer is no. It does not come close.

Cookie consent and HIPAA authorization are two distinct legal mechanisms, governed by different laws, requiring different elements, and protecting different interests. Confusing them is one of the most common and most consequential compliance mistakes healthcare marketing teams make.

What Cookie Consent Actually Authorizes

Cookie consent banners exist because of privacy regulations like the EU's General Data Protection Regulation (GDPR), California's Consumer Privacy Act (CCPA/CPRA), and a growing number of state privacy laws. These regulations require websites to inform visitors about data collection practices and, in many jurisdictions, obtain affirmative consent before setting non-essential cookies or tracking technologies.

A valid cookie consent mechanism typically covers what types of cookies and trackers the site uses (analytics, advertising, functional), what data those technologies collect, which third parties receive the data, and the visitor's right to opt out or withdraw consent.

When a visitor clicks "Accept All" on a cookie banner, they are granting permission under these privacy regulations for the website to use the specified tracking technologies. The consent applies to data collection practices governed by privacy law.

Here is what cookie consent does not do: it does not satisfy HIPAA's requirements for sharing protected health information. HIPAA and state privacy laws are separate legal frameworks with separate requirements. Meeting one does not discharge your obligations under the other.

What HIPAA Authorization Requires

HIPAA authorization is a formal, written permission from a patient that allows a covered entity to use or disclose their protected health information for a specific purpose. The Privacy Rule at 45 CFR 164.508 specifies the exact elements a valid authorization must contain.

A valid HIPAA authorization must include a specific description of the PHI to be used or disclosed, the name of the person or entity authorized to make the disclosure, the name of the person or entity to whom the disclosure will be made, a description of the purpose of the disclosure, an expiration date or event, the individual's signature and date, and a statement about the individual's right to revoke the authorization.

Compare that to a cookie banner that says "We use cookies to improve your experience." The gap between the two is not a technicality. It is a chasm.

A cookie banner does not name the specific health information being shared. It does not identify Google, Meta, or Hotjar by name as recipients. It does not describe the purpose as "sharing your browsing behavior on our mental health services page with Facebook's advertising platform." It does not include an expiration date. And it is not signed by the patient.

The Overlap Zone Where Confusion Creates Liability

The confusion between cookie consent and HIPAA authorization is understandable. Both involve getting permission from individuals before using their data. Both are responses to concerns about privacy. And on a healthcare website, the same user action (visiting a webpage) triggers requirements under both frameworks simultaneously.

When a patient visits a hospital website and browses the oncology department page, two regulatory regimes activate at the same time. Privacy law requires that the website disclose its tracking practices and (in many jurisdictions) obtain consent before setting analytics cookies. HIPAA requires that the hospital not disclose the patient's PHI (including the fact that they are researching cancer services) to third parties without proper authorization.

The cookie banner addresses the first requirement. It does nothing for the second.

NewYork-Presbyterian Hospital ($300K NY AG, 2023). NYP used third-party tracking pixels on its website for marketing from 2016 to 2022. The hospital had no internal policies or procedures for vetting tracking tools before deployment. The breach affected over 54,000 individuals and was enforced by the New York Attorney General. Source

NYP's case illustrates the governance failure that often accompanies the cookie-consent-equals-compliance assumption. The hospital likely had privacy policies and possibly consent mechanisms on its website. But no amount of cookie consent addresses the fundamental issue: tracking pixels were transmitting health-related browsing data to third parties that had no BAA, no HIPAA obligation, and no reason to protect the data.

Mass General Brigham ($18.4M class action, 2024). Thirty-eight named providers used cookies, tracking pixels, and web analytics tools on hospital websites. These tools collected visitor data and shared it with third parties without consent. The class period spanned May 2016 through July 2021. Source

Mass General Brigham's settlement is particularly instructive. The case was litigated as a cookie consent violation, meaning the providers did not even meet the lower bar of privacy law consent, let alone HIPAA authorization. When healthcare organizations fail to implement even basic cookie consent, the HIPAA authorization gap is guaranteed to exist alongside it.

Why Consent Management Platforms Alone Do Not Solve This

Consent management platforms (CMPs) like OneTrust, Cookiebot, and TrustArc are valuable tools for managing cookie consent under privacy regulations. They provide banner configuration, consent logging, category-based script blocking, and compliance documentation.

But a CMP manages consent for privacy law purposes. It does not manage HIPAA authorization. Installing a CMP on a healthcare website does not prevent PHI from flowing to third parties. It manages whether tracking scripts load at all, which is a necessary first step, but it is not sufficient.

Even when a CMP correctly blocks analytics scripts until consent is granted, the consent the visitor provides is cookie consent, not HIPAA authorization. Once the visitor clicks "Accept" and the scripts load, data begins flowing to third-party servers. The CMP has done its privacy law job. The HIPAA problem remains untouched.

The compliant approach layers consent management with architectural controls. A CMP handles privacy law obligations. Server-side architecture handles HIPAA obligations by ensuring that even when tracking scripts are authorized by the visitor, the data flows through controlled, server-side pipelines rather than directly from the browser to third-party platforms.

Consent as Healthcare's Next Compliance Frontier

The distinction between cookie consent and HIPAA authorization is becoming more important, not less. State privacy laws are proliferating. Washington's My Health My Data Act creates consent requirements specifically for health data that go beyond both GDPR and HIPAA. Other states are following with their own health-data-specific provisions.

At the same time, patient expectations around data privacy are evolving. Patients increasingly expect that their healthcare providers handle digital data with the same care they handle medical records. A cookie banner that enables tracking across advertising platforms violates that expectation regardless of its legal validity.

Healthcare organizations that build consent infrastructure capable of managing both privacy law consent and HIPAA-grade data controls will be positioned for this regulatory future. Those that treat a cookie banner as a universal compliance solution will find themselves exposed as regulations tighten and enforcement increases.

Server-side consent gating bridges both frameworks. When consent verification happens at the server level, you can enforce different rules for different regulatory requirements. Privacy law consent determines whether tracking occurs at all. HIPAA-grade controls determine what data reaches which downstream systems and under what conditions. The two work together rather than being conflated into a single "Accept All" button.

FAQ

If a patient clicks "Accept All" on our cookie banner, does that count as HIPAA authorization?

No. Cookie consent under privacy laws (GDPR, CCPA) and HIPAA authorization are separate legal requirements with separate elements. HIPAA authorization requires specific elements including a description of the PHI, named recipients, stated purpose, expiration date, and the individual's signature. A cookie banner click satisfies none of these requirements.

Do we need both a cookie consent banner and HIPAA authorization for website tracking?

If you are a HIPAA-covered entity using tracking technologies on your website, you may need to address both frameworks. A cookie consent mechanism addresses state and international privacy law requirements. HIPAA authorization (or a compliant alternative architecture like server-side tracking with a BAA-covered vendor) addresses HIPAA requirements. Neither satisfies the other.

Can a consent management platform be configured to meet HIPAA requirements?

A CMP can be part of a HIPAA-compliant approach, but it cannot satisfy HIPAA requirements alone. A CMP manages whether scripts load based on consent categories. HIPAA compliance requires that any PHI shared with third parties is covered by a BAA, that the sharing serves a permitted purpose, and that the patient has provided authorization meeting specific regulatory elements. The CMP handles the gating. The downstream architecture, BAA coverage, and data controls handle the HIPAA piece.

What about state health privacy laws like Washington's My Health My Data Act?

State health privacy laws like Washington's MHMD Act create additional consent requirements specifically for health data that may apply even to entities not covered by HIPAA. These laws often require consent before collecting or sharing health data, with specific disclosure requirements. Healthcare organizations need to address HIPAA authorization, state privacy law consent, and general cookie consent as separate (sometimes overlapping) obligations. Server-side consent management that can enforce different rules for different jurisdictions is increasingly essential.

Should our cookie banner mention HIPAA at all?

Generally, no. Cookie banners should address the privacy law requirements they are designed to fulfill (identifying tracking technologies, offering consent choices). Mentioning HIPAA on a cookie banner could create confusion and potentially imply that clicking "Accept" satisfies HIPAA requirements, which it does not. HIPAA authorization, when required, should be handled through separate, purpose-built consent workflows that meet the Privacy Rule's specific requirements.

Understanding the difference between cookie consent and HIPAA authorization is the starting point. Building infrastructure that addresses both is the destination. Ours Privacy provides server-side consent management that handles privacy law compliance and HIPAA-grade data controls in a single architecture.

Related reading:

• What Is PHI? A Healthcare Marketer's Guide

• HIPAA and Marketing: What the Privacy Rule Actually Says

• What Is a BAA and Why Does Your Analytics Vendor Need One?

• State Health Privacy Laws: A Map of What Applies Where